Articles

Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Worcester Polytechnic Institute, Department of Biology, Worcester, MA, USA
Worcester Polytechnic Institute, Department of Biology, Worcester, MA, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA
Vol. 102 No. 4 (2017): April, 2017 https://doi.org/10.3324/haematol.2016.158394